Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc. but Wojcicki complained about the bidding process, ...

The co-founder of bankrupt genetic analysis company 23andMe won an auction for the firm’s assets, agreeing, along with a ...

New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...

TTAM Commits to Comply with Company’s Privacy Policy and All Applicable Laws TTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards to Enhance Protections for Customer Data ...

Me's Interim CEO Joe Selsavage said 1.9 million customers have asked the company delete their data since March.

House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...

Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S. Bankruptcy Court for ...

The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...